Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00242983

Locations


Japan
	Asahikawa Medical College
	Asahikawa, Japan, 078 8510
	Fujisawa City Hospital
	Kanagawa, Japan, 251-8550
	Gunma Cancer Center
	Gunma, Japan, 373-8550
	Ichinomiyanishi Hospital
	Aichi, Japan, 491-0201
	Junshinkai Tsuna Hospital
	Hyogo, Japan, 663-8501
	Koseiren Takaoka Hospital
	Toyama, Japan, 933-8555
	Miyagi Cancer Center
	Miyagi, Japan, 981-1293
	National Cancer Center Hospital East
	Chiba-ken, Japan, 277-8577
	National Hospital Organization - Dohoku National Hospital
	Hokkaido, Japan, 070-0901
	National Hospital Organization - Minamikyoto Medical Center
	Kyoto, Japan, 610-0113
	Toyohashi Municipal Hospital
	Aichi, Japan, 466-8560
	National Hospital Organization - Okayama Medical Center
	Okayama, Japan, 701-1192
	National Hospital Organization - Osaka National Hospital
	Osaka, Japan, 591-8555
	Osaka General Medical Center
	Osaka-shi, Japan, 558-0056
	Osaka Kosei Nenkin Hospital
	Osaka, Japan, 553-0003
	Saitama Cardiovascular and Respiratory Center
	Saitama, Japan, 360-0105
	Shikoku Cancer Center Hospital
	Ehime, Japan, 790-0007
	Takarazuka Municipal Hospital
	Hyogo, Japan, 665-0827
	Tokyo Medical University
	Tokyo, Japan, 160
	Tottori University Hospital
	Tottori, Japan, 683-8504
	National Hospital Organization - Nishigunma National Hospital
	Gumna, Japan, 377-8511

Sponsors and Collaborators

National Hospital Organization Kinki-chuo Chest Medical Center

Investigators


Study Chair:	Masaaki Kawahara, MD	National Hospital Organization - Osaka National Hospital